Area of research
Psychiatry and Mental health · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies, Neuroscience and Neuropharmacology Research, and EEG and Brain-Computer Interfaces.
Treatment Response to Antiseizure Medications in People With Newly Diagnosed Focal Epilepsy
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy
Superior Verbal Memory Outcome After Stereotactic Laser Amygdalohippocampotomy
Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy
Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: A US database analysis
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy
Risk of pharmacokinetic interactions between antiepileptic and other drugs in older persons and factors associated with risk
Detection of generalized tonic–clonic seizures using surface electromyographic monitoring
What does the U.S. Medicare administrative claims database tell us about initial antiepileptic drug treatment for older adults with new‐onset epilepsy?
Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey
Adherence to antiepileptic drugs among diverse older Americans on Part D Medicare
Descriptive epidemiology of epilepsy in the <scp>U</scp>.<scp>S</scp>. population: A different approach
Estimating Epilepsy Incidence and Prevalence in the US Pediatric Population Using Nationwide Health Insurance Claims Data
Psychiatric and neurologic risk factors for incident cases of new‐onset epilepsy in older adults: Data from U.S. Medicare beneficiaries
BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy
Tiagabine in clinical practice: effects on seizure control and behavior
Incidence and prevalence of epilepsy among older US Medicare beneficiaries
Adherence to antiepilepsy drug therapy
Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy
Long‐term safety and efficacy in patients with uncontrolled partial‐onset seizures treated with adjunctive lacosamide: Results from a phase III open‐label extension trial
Recurrent mutations in<i><scp>DNAJC5</scp></i>cause autosomal dominant Kufs disease